Your browser is no longer supported. Please, upgrade your browser.
STIM Neuronetics, Inc. daily Stock Chart
Neuronetics, Inc.
Index- P/E- EPS (ttm)-1.84 Insider Own8.20% Shs Outstand18.68M Perf Week7.10%
Market Cap34.10M Forward P/E- EPS next Y-0.71 Insider Trans6.33% Shs Float15.42M Perf Month-12.11%
Income-34.10M PEG- EPS next Q-0.52 Inst Own76.20% Short Float2.14% Perf Quarter0.00%
Sales61.40M P/S0.56 EPS this Y41.30% Inst Trans3.83% Short Ratio0.55 Perf Half Y-53.44%
Book/sh1.95 P/B1.01 EPS next Y60.80% ROA-33.80% Target Price- Perf Year-84.96%
Cash/sh3.66 P/C0.54 EPS next 5Y- ROE-68.80% 52W Range1.25 - 13.31 Perf YTD-56.35%
Dividend- P/FCF- EPS past 5Y- ROI-34.00% 52W High-85.29% Beta-
Dividend %- Quick Ratio5.90 Sales past 5Y- Gross Margin74.90% 52W Low56.65% ATR0.22
Employees235 Current Ratio6.20 Sales Q/Q-9.40% Oper. Margin-50.60% RSI (14)50.02 Volatility9.70% 11.47%
OptionableNo Debt/Eq0.94 EPS Q/Q-61.70% Profit Margin-55.60% Rel Volume0.85 Prev Close1.96
ShortableYes LT Debt/Eq0.94 EarningsMay 05 BMO Payout- Avg Volume594.46K Price1.96
Recom1.80 SMA202.06% SMA50-3.19% SMA200-49.04% Volume139,937 Change-0.10%
Feb-06-20Initiated BTIG Research Buy $11
Jul-24-18Initiated Canaccord Genuity Buy
Jun-26-20 07:00AM  
Jun-10-20 01:01PM  
Jun-04-20 04:30PM  
Jun-03-20 09:53AM  
May-12-20 05:21PM  
May-07-20 08:00AM  
May-05-20 07:30AM  
Apr-21-20 08:00AM  
Apr-09-20 02:35PM  
Apr-08-20 04:11PM  
Mar-30-20 07:30AM  
Mar-16-20 07:30AM  
Mar-13-20 01:18PM  
Mar-06-20 10:15AM  
Mar-05-20 12:54PM  
Mar-03-20 07:30AM  
Feb-25-20 12:30PM  
Feb-18-20 08:00AM  
Feb-13-20 07:00AM  
Feb-12-20 04:05PM  
Jan-21-20 07:30AM  
Jan-16-20 10:14AM  
Dec-20-19 05:47PM  
Nov-25-19 07:30AM  
Nov-21-19 08:00AM  
Nov-07-19 07:30AM  
Nov-05-19 08:45AM  
Nov-01-19 07:30AM  
Oct-30-19 01:53PM  
Oct-29-19 10:33AM  
Oct-28-19 07:30AM  
Oct-22-19 07:30AM  
Oct-21-19 07:30AM  
Oct-03-19 07:30AM  
Oct-01-19 07:30AM  
Sep-04-19 07:30AM  
Aug-27-19 01:15PM  
Aug-19-19 07:30AM  
Aug-07-19 09:24PM  
Aug-06-19 08:45AM  
Aug-01-19 07:30AM  
Jul-29-19 07:30AM  
Jul-25-19 04:30PM  
Jul-23-19 08:00AM  
Jul-17-19 04:19PM  
Jul-08-19 07:30AM  
Jul-03-19 07:31AM  
Jul-02-19 09:03PM  
Jun-27-19 07:15AM  
Jun-05-19 07:30AM  
Jun-03-19 07:30AM  
May-28-19 09:43PM  
May-23-19 04:30PM  
May-15-19 05:38PM  
May-14-19 07:30AM  
May-08-19 04:24PM  
May-07-19 07:41AM  
Apr-26-19 11:49AM  
Apr-23-19 08:00AM  
Mar-27-19 04:15PM  
Mar-26-19 08:00AM  
Mar-25-19 05:43PM  
Mar-21-19 08:00AM  
Mar-05-19 12:07PM  
Feb-21-19 08:00AM  
Feb-19-19 04:15PM  
Feb-15-19 08:00AM  
Jan-07-19 08:00AM  
Dec-20-18 09:35AM  
Nov-27-18 06:29PM  
Nov-15-18 08:00AM  
Nov-13-18 08:00AM  
Nov-06-18 07:21AM  
Oct-23-18 08:00AM  
Oct-18-18 10:52AM  
Oct-01-18 08:00AM  
Aug-14-18 07:00AM  
Jul-31-18 06:00AM  
Jul-27-18 07:45AM  
Jul-24-18 07:44AM  
Jul-23-18 04:58PM  
Jul-11-18 06:56AM  
Jul-02-18 04:48PM  
Jun-28-18 07:00AM  
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with psychiatric disorders in the United States, Japan, and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrist customers. Neuronetics, Inc. was founded in 2003 and is headquartered in Malvern, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Farley Brian EDirectorMar 13Buy2.2840,00091,200217,606Mar 16 04:49 PM
Farley Brian EDirectorMar 12Buy2.1810,00021,800177,606Mar 16 04:49 PM
Guthrie DanielChief Commercial OfficerMar 12Buy2.365,00011,800146,855Mar 13 04:26 PM
Furlong StephenVP and CFOMar 10Buy2.0025,00050,000274,184Mar 11 05:31 PM
MACAN WILLIAM ANDREWSr. VP, GC, CCO and SecretaryMar 10Buy2.005,00010,000182,399Mar 11 05:28 PM
Thatcher ChristopherPresident and CEOMar 04Option Exercise0.8720,00017,400249,811Mar 04 08:16 PM
Harper GregoryVP of R&D, Ops. and Prod. Dev.Dec 16Buy4.4010,00044,00075,480Dec 18 04:51 PM
Guthrie DanielChief Commercial OfficerDec 02Buy4.282,50010,70049,074Dec 03 04:10 PM
CAMPE STEPHEN MDirectorNov 25Buy4.232,50010,57529,410Nov 26 06:41 AM
CAMPE STEPHEN MDirectorNov 22Buy4.269,50040,47026,910Nov 26 06:41 AM
Farley Brian EDirectorNov 18Buy4.2711,00046,970147,606Nov 18 07:45 PM
Furlong StephenCFO and SecretaryNov 15Buy4.4922,959103,08688,934Nov 19 04:40 PM
Farley Brian EDirectorNov 14Buy4.6019,00087,400136,606Nov 18 07:45 PM